Johnson Matthey (LON:JMAT – Get Free Report) had its price target raised by investment analysts at Berenberg Bank from GBX 2,100 to GBX 2,300 in a report released on Monday,Digital Look reports. The brokerage presently has a “buy” rating on the stock. Berenberg Bank’s price target indicates a potential upside of 7.30% from the company’s current price.
JMAT has been the subject of a number of other research reports. Jefferies Financial Group reissued a “restricted” rating on shares of Johnson Matthey in a report on Friday. UBS Group reissued a “neutral” rating and set a GBX 2,200 target price on shares of Johnson Matthey in a report on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Johnson Matthey from GBX 2,120 to GBX 2,400 and gave the company a “buy” rating in a report on Friday. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Johnson Matthey currently has a consensus rating of “Moderate Buy” and an average target price of GBX 2,298.33.
View Our Latest Analysis on JMAT
Johnson Matthey Stock Performance
Johnson Matthey (LON:JMAT – Get Free Report) last announced its earnings results on Thursday, May 28th. The company reported GBX 128.50 EPS for the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%.The business had revenue of GBX 1,257.30 billion during the quarter. Sell-side analysts anticipate that Johnson Matthey will post 173.4112903 EPS for the current fiscal year.
Insider Buying and Selling
In related news, insider Liam Condon purchased 14 shares of the company’s stock in a transaction dated Wednesday, March 11th. The stock was acquired at an average cost of GBX 1,941 per share, for a total transaction of £271.74. Also, insider Alastair Judge purchased 14 shares of the company’s stock in a transaction dated Wednesday, April 15th. The stock was bought at an average price of GBX 2,022 per share, with a total value of £283.08. Insiders bought 72 shares of company stock valued at $146,198 over the last 90 days. Company insiders own 0.51% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Read More
- Five stocks we like better than Johnson Matthey
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
